Lymphoma & Plasma Cell Disorders
Feature
How is oncology adapting to COVID-19?
Feature
Disruptions in cancer care in the era of COVID-19
Conference Coverage
Largest meeting on cancer research canceled: AACR
News
FDA approves new drug for relapsed/refractory multiple myeloma
From the Journals
Late effects in young cancer survivors underscore importance of high-risk screening
Childhood cancer survivors have higher standardized mortality ratios than early-adolescent and young adult cancer survivors.
From the Journals
Psoriasis elevates cancer risk
No increased cancer risk occurred in psoriasis patients treated with biologics or in patients with psoriatic arthritis.
News
Asymptomatic, erythematous papules on the neck
A healthy 65-year-old white female presented with asymptomatic, erythematous papules on her neck, which she has experienced previously.
News
FDA: Cell phones still look safe
The available evidence does not suggest a causal link between cell phone use and cancer, according to the FDA.
From the Journals
Older NHL survivors show worse cognitive decline
From the Journals
CRISPR-engineered T cells may be safe for cancer, but do they work?
All three patients who received CRISPR-engineered T cells in a phase 1 trial experienced cancer progression but minimal toxicity.
From the Journals
Global project reveals cancer’s genomic playbook
The Pan-Cancer Analysis of Whole Genomes, an international collaboration, reveals the complexity of oncogenesis.